Back to Journals » Drug Design, Development and Therapy » Volume 2

Original Research

A phase I clinical study of VB4-845: Weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck

       
Total article views   HTML views PDF downloads Totals
6,483 Dovepress* 6,483+ 2,415 8,898
Totals 6,483 2,415 8,898
*Since 25 June 2008
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 0 5

View citations on Google Scholar